{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T21:51:21Z","timestamp":1794088281282,"version":"4.8.0"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,1]]},"abstract":"<jats:sec>\n                    <jats:title>OBJECTIVE:<\/jats:title>\n                    <jats:p>To evaluate whether retropubic midurethral sling combined with onabotulinumtoxinA is more effective than sling alone in improving mixed urinary incontinence symptoms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>We conducted a prospective, double-blind, randomized, controlled trial of women with mixed urinary incontinence, planning to undergo midurethral sling. Women were randomly assigned to receive 100 unites of intradetrusor onabotulinumtoxinA or placebo during surgery. Participants completed the PGI-S (Patient Global Impression of Severity), the UDI-6 (Urinary Distress Inventory, Short Form), and the PFIQ-7 (Pelvic Floor Impact Questionnaire\u2013Short Form 7) before and 3 months after surgery, and the primary outcome, PGI-I (Patient Global Impression of Improvement), 3 months postoperatively. Primary outcome was PGI-I score at 3 months for overall incontinence. We considered women \u201cimproved\u201d with answers of \u201cvery much better\u201d or \u201cmuch better\u201d on the PGI-I. Assuming a PGI-I response of \u201cimproved\u201d in 66% of placebo and 93% of onabotulinumtoxinA participants, 68 women were needed to show a significant difference with 80% power at 0.05 significance level.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>\n                      From March 2016 to November 2019, 78 women completed a 3-month follow-up (onabotulinumtoxinA: 41; placebo: 37). Mean age was 51 years (\u00b110). On the PGI-I, the number who \u201cimproved\u201d did not differ between groups at 3 months (83% vs 84%,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =1.0). The onabotulinumtoxinA group had less severe urgency symptoms as indicated by median urgency PGI-S scores (1 [interquartile range 1\u20132] vs 2 [interquartile range 1\u20133],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.033) and greater improvement in urgency symptoms based on median urgency PGI-I score (1 [interquartile range 1\u20133] vs 2 [interquartile range 2\u20134],\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.028). At 3 months, median UDI-6, PFIQ-7, and PGI-S scores improved significantly from baseline in both groups. Similarly, UDI-6 and PFIQ-7 scores did not differ between groups. More women in the onabotulinumtoxinA arm initiated intermittent self-catheterization, (3% placebo; 12% onabotulinumtoxinA,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.20) and experienced urinary tract infections (5% placebo; 22% onabotulinumtoxinA,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =.051), but these did not differ statistically.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Concurrent intradetrusor onabotulinumtoxinA injection did not improve overall incontinence symptoms at 3 months compared with placebo among women with mixed urinary incontinence undergoing midurethral sling placement. Women with mixed urinary incontinence undergoing sling report significant improvement in overall incontinence symptoms, regardless of the addition of onabotulinumtoxinA injections, but those receiving concurrent onabotulinumtoxinA injections reported less urgency severity and greater improvement in urgency symptoms at 3 months.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CLINICAL TRIAL REGISTRATION:<\/jats:title>\n                    <jats:p>ClinicalTrials.gov, NCT02678377.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/aog.0000000000004198","type":"journal-article","created":{"date-parts":[[2020,12,3]],"date-time":"2020-12-03T17:04:52Z","timestamp":1607015092000},"page":"12-20","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":11,"title":["Concurrent Retropubic Midurethral Sling and OnabotulinumtoxinA for Mixed Urinary Incontinence"],"prefix":"10.1097","volume":"137","author":[{"given":"Alix","family":"Komar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol E.","family":"Bretschneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret G.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Lewicky-Gaupp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Geynisman-Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meera","family":"Tavathia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly","family":"Kenton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2020,12,1]]},"reference":[{"key":"R1-20260601","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00192-009-0976-9","article-title":"An International Urogynecological Association (IUGA)\/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction","volume":"21","author":"Haylen","year":"2010","journal-title":"Int Urogynecol J"},{"key":"R2-20260601","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1007\/s00192-008-0637-4","article-title":"Mixed incontinence is more bothersome than pure incontinence subtypes","volume":"19","author":"Dooley","year":"2008","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R3-20260601","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s00192-017-3314-7","article-title":"Clinical epidemiological insights into urinary incontinence","volume":"28","author":"Minassian","year":"2017","journal-title":"Int Urogynecol J"},{"issue":"Suppl 2","key":"R4-20260601","first-page":"3","article-title":"Prevalence and natural history of female incontinence","volume":"32","author":"Hampel","year":"1997","journal-title":"Eur Urol"},{"key":"R5-20260601","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S0895-4356(00)00232-8","article-title":"A community-based epidemiological survey of female urinary incontinence: the Norwegian EPINCONT study. Epidemiology of Incontinence in the County of Nord-Tr\u00f8ndelag","volume":"53","author":"Hannestad","year":"2000","journal-title":"J Clin Epidemiol"},{"key":"R6-20260601","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/s00192-005-1314-5","article-title":"Epidemiology of prolapse and incontinence questionnaire: validation of a new epidemiologic survey","volume":"16","author":"Lukacz","year":"2005","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"R7-20260601","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0895-4356(94)00147-I","article-title":"Diagnostic classification of female urinary incontinence: an epidemiological survey corrected for validity","volume":"48","author":"Sandvik","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"R8-20260601","first-page":"130","article-title":"Economic burden of urgency urinary incontinence in the United States: a systematic review","volume":"20","author":"Coyne","year":"2014","journal-title":"J Manag Care Pharm"},{"key":"R9-20260601","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.juro.2017.06.061","article-title":"Surgical treatment of female stress urinary incontinence: AUA\/SUFU guideline","volume":"198","author":"Kobashi","year":"2017","journal-title":"J Urol"},{"key":"R10-20260601","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/nau.20870","article-title":"Fourth international consultation on incontinence recommendations of the international scientific committee: evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence","volume":"29","author":"Abrams","year":"2010","journal-title":"Neurourol Urodyn"},{"key":"R11-20260601","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.5489\/cuaj.4584","article-title":"The management of mixed urinary incontinence in women","volume":"11","author":"Welk","year":"2017","journal-title":"Can Urol Assoc J"},{"key":"R12-20260601","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1464-410X.2003.04519.x","article-title":"Stress incontinence surgery for patients presenting with mixed incontinence and a normal cystometrogram","volume":"92","author":"Osman","year":"2003","journal-title":"BJU Int"},{"key":"R13-20260601","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1001\/jama.2019.12467","article-title":"Effect of behavioral and pelvic floor muscle therapy combined with surgery vs surgery alone on incontinence symptoms among women with mixed urinary incontinence: the ESTEEM randomized clinical trial","volume":"322","author":"Sung","year":"2019","journal-title":"JAMA"},{"key":"R14-20260601","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1208872","article-title":"Anticholinergic therapy vs. onabotulinumtoxinA for urgency urinary incontinence","volume":"367","author":"Visco","year":"2012","journal-title":"N Engl J Med"},{"key":"R15-20260601","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.cct.2011.09.019","article-title":"Anticholinergic versus botulinum toxin A comparison trial for the treatment of bothersome urge urinary incontinence: ABC trial","volume":"33","author":"Visco","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"R16-20260601","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/j.juro.2010.08.021","article-title":"Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial","volume":"184","author":"Dmochowski","year":"2010","journal-title":"J Urol"},{"key":"R17-20260601","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1007\/BF00451721","article-title":"Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence program in women (CPW) research group","volume":"3","author":"Shumaker","year":"1994","journal-title":"Qual Life Res"},{"key":"R18-20260601","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/nau.1930140206","article-title":"Short forms to assess life quality and symptom distress for urinary incontinence in women: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence program for women research group","volume":"14","author":"Uebersax","year":"1995","journal-title":"Neurourol Urodyn"},{"key":"R19-20260601","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1067\/mob.2003.379","article-title":"Validation of two global impression questionnaires for incontinence","volume":"189","author":"Yalcin","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"R20-20260601","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1097\/SPV.0b013e3181cb97f0","article-title":"A comparison of transobturator versus retropubic midurethral slings for mixed urinary incontinence","volume":"16","author":"Kudish","year":"2010","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R21-20260601","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1007\/s11934-010-0133-5","article-title":"Can we predict if overactive bladder symptoms will resolve after sling surgery in women with mixed urinary incontinence?","volume":"11","author":"Katsumi","year":"2010","journal-title":"Curr Urol Rep"},{"key":"R22-20260601","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/fampra\/cml018","article-title":"Perceptions and behaviours of women with bladder control problems","volume":"23","author":"Diokno","year":"2006","journal-title":"Fam Pract"},{"key":"R23-20260601","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/SPV.0000000000000496","article-title":"Real-world retention rates after intravesical onabotulinumtoxinA for idiopathic overactive bladder","volume":"24","author":"Liberman","year":"2018","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R25-20260601","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0912658","article-title":"Retropubic versus transobturator midurethral slings for stress incontinence","volume":"362","author":"Richter","year":"2010","journal-title":"N Engl J Med"},{"key":"R26-20260601","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/SPV.0000000000000425","article-title":"Management of mesh and graft complications in gynecologic surgery","volume":"23","year":"2017","journal-title":"Female Pelvic Med Reconstr Surg"},{"key":"R27-20260601","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1097\/01.ju.0000060119.43064.f6","article-title":"Management of vaginal erosion of polypropylene mesh slings","volume":"169","author":"Kobashi","year":"2003","journal-title":"J Urol"},{"key":"R28-20260601","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1471-0528.2011.02915.x","article-title":"Persistence of urgency and urge urinary incontinence in women with mixed urinary symptoms after midurethral slings: a multivariate analysis","volume":"118","author":"Lee","year":"2011","journal-title":"BJOG Int J Obstet Gynaecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T15:00:14Z","timestamp":1780326014000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/AOG.0000000000004198"}},"subtitle":["A Randomized Controlled Trial"],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000004198","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2020-04-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-08-06","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}